Ahead of Asembia’s AXS26, CoverMyMeds convened industry leaders across biopharma to explore the forces driving change in 2026. Watch our in-depth discussion exploring how AI, policy shifts and collaborative patient support are reshaping access and affordability — and gain a clearer understanding of the trends and innovations likely to matter most in the year ahead.
This roundtable assembled thought leaders from across the industry to explore the most pressing access and affordability challenges facing biopharma in 2026.
From AI-enabled patient services to evolving policy, each participant brings unique insights on what's driving change—and what biopharma brands need to know to stay ahead.
An accomplished executive healthcare leader with over 15 years of experience in the industry, Miranda began her career as a registered nurse in hematology and oncology and quickly advanced to leadership roles. While serving as the Associate Director of Emergency Services at The Ohio State University Comprehensive Cancer Center, she and her team successfully launched the first fully integrated oncology emergency department in the United States. Since joining CoverMyMeds in 2017, she has successfully built and led high-performing clinical, operational and product teams. As the Vice President of Specialty Product, she has responsibility for improving the medication access journey for patients on specialty medications. Miranda holds a Doctor of Nursing Practice and is involved in a number of community and professional organizations including the Ronald McDonald House of Central Ohio, Nationwide Children’s Hospital Foundation, and Pelotonia.
Megan is a seasoned leader with over a decade of experience driving innovation in healthcare technology. Since joining McKesson in 2013, Megan has held various roles in product management, dedicating her career to supporting pharmacy and pharmaceutical customers. Most recently, she served as Vice President of Product for Hub Solutions, leading strategic product development to enhance patient access and affordability, building on her prior leadership of patient affordability solutions. Through her diverse experience, Megan continues to successfully lead teams in tackling complex challenges, particularly within the pharmaceutical industry. Based in Atlanta, Georgia, Megan is recognized for her strategic vision, collaborative leadership style and commitment to creating meaningful, scalable solutions that improve health outcomes.
Ashwin Singhania has over 20 years of experience in life sciences advising biopharma companies to support their strategic growth in bringing new products to market to enhance patient care. As a principal within Strategy and Transactions at EY-Parthenon, Ernst & Young LLP, Ashwin focuses on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. His career includes roles with large pharmaceutical organizations, specialty pharmaceuticals and prerevenue biotechs. He also supports private equity for investments in biopharmaceutical and biopharmaceutical services.
In her current leadership role, Fauzea champions public policy strategies that drive the company's mission to improve health outcomes. With a keen focus on patient-first solutions, Fauzea collaborates across the enterprise to address the diverse needs of distributors, wholesalers, community providers, health systems, pharmacies, manufacturers, technology vendors and consumers. A seasoned policy expert with over 25 years of experience, Fauzea has a proven track record in assessing the impact of state and federal policies on patient access, provider reimbursement, and the life sciences industry.
Nico Saraceno is the Senior Editor of Nutritional Outlook, a publication for the dietary supplement, healthy foods, and natural products market. He also has over a half-decade of experience covering pharma’s patient access and affordability space via his time with Pharmaceutical Commerce.
An accomplished executive healthcare leader with over 15 years of experience in the industry, Miranda began her career as a registered nurse in hematology and oncology and quickly advanced to leadership roles. While serving as the Associate Director of Emergency Services at The Ohio State University Comprehensive Cancer Center, she and her team successfully launched the first fully integrated oncology emergency department in the United States. Since joining CoverMyMeds in 2017, she has successfully built and led high-performing clinical, operational and product teams. As the Vice President of Specialty Product, she has responsibility for improving the medication access journey for patients on specialty medications. Miranda holds a Doctor of Nursing Practice and is involved in a number of community and professional organizations including the Ronald McDonald House of Central Ohio, Nationwide Children’s Hospital Foundation, and Pelotonia.
Megan is a seasoned leader with over a decade of experience driving innovation in healthcare technology. Since joining McKesson in 2013, Megan has held various roles in product management, dedicating her career to supporting pharmacy and pharmaceutical customers. Most recently, she served as Vice President of Product for Hub Solutions, leading strategic product development to enhance patient access and affordability, building on her prior leadership of patient affordability solutions. Through her diverse experience, Megan continues to successfully lead teams in tackling complex challenges, particularly within the pharmaceutical industry. Based in Atlanta, Georgia, Megan is recognized for her strategic vision, collaborative leadership style and commitment to creating meaningful, scalable solutions that improve health outcomes.
Ashwin Singhania has over 20 years of experience in life sciences advising biopharma companies to support their strategic growth in bringing new products to market to enhance patient care. As a principal within Strategy and Transactions at EY-Parthenon, Ernst & Young LLP, Ashwin focuses on corporate and commercial strategy for biopharma across growth strategy, transaction support and operating model transformation. His career includes roles with large pharmaceutical organizations, specialty pharmaceuticals and prerevenue biotechs. He also supports private equity for investments in biopharmaceutical and biopharmaceutical services.
In her current leadership role, Fauzea champions public policy strategies that drive the company's mission to improve health outcomes. With a keen focus on patient-first solutions, Fauzea collaborates across the enterprise to address the diverse needs of distributors, wholesalers, community providers, health systems, pharmacies, manufacturers, technology vendors and consumers. A seasoned policy expert with over 25 years of experience, Fauzea has a proven track record in assessing the impact of state and federal policies on patient access, provider reimbursement, and the life sciences industry.
Nico Saraceno is the Senior Editor of Nutritional Outlook, a publication for the dietary supplement, healthy foods, and natural products market. He also has over a half-decade of experience covering pharma’s patient access and affordability space via his time with Pharmaceutical Commerce.
